Advertisement

Topics

Zealand Pharma's dasiglucagon Phase 2a results at the 11th International Conference on ATTD

04:09 EST 15 Feb 2018 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Press release - No. 3/2018 Zealand Pharma's dasiglucagon Phase 2a results will be presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes Dasiglucagon was dosed using the automated ...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Zealand Pharma's dasiglucagon Phase 2a results at the 11th International Conference on ATTD"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...